Disease / condition

Metastatic Colorectal Cancer clinical trials

Free access to 467 studies·10+ countries·Updated daily86 recruiting
467
Total trials
10+
Countries
10+
Sponsors
86
Recruiting
By phase
Phase 2219
N/A99
Phase 350
Phase 141
Early Phase 133
By status
Completed201
Recruiting86
Unknown50
Not yet recruit...42
Terminated41
Top countries
China72
United States of America58
France38
Italy30
Germany16
Top sponsors
Amgen13
Sun Yat-sen Univer...10
Spanish Cooperativ...9
Gruppo Oncologico ...7
Bayer7
Recent trials
Latest clinical trials for Metastatic Colorectal Cancer
NCT06411600·Phase 2Not yet recr...
Combination Therapy for BRAF-V600E Metastatic CRCm
Vall d'Hebron Institute of Onc...
NCT06363552·Phase 2Not yet recr...
A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer
Tianshu LiuChina
NCT06403709·Phase 2Recruitment ...
Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients
Cancer Institute and Hospital,...China
NCT06341309·Phase 1/2Not yet recr...
Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer
West China Hospital
NCT06341296·Phase 2Not yet recr...
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
West China Hospital
NCT06347198·Phase 1Recruiting
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Wuhan Union Hospital, ChinaChina
NCT06242067·Phase 2Recruiting
Second-line Treatment of Metastatic Colorectal Cancer
Qilu Hospital of Shandong Univ...China
NCT06243393·Phase 2/3Not yet recr...
Sacituzumab Govitecan in Metastatic Colorectal Cancer
University Hospital HeidelbergGermany
NCT06231017·Phase 2Recruiting
Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer
The First Affiliated Hospital ...China
NCT06225622·Phase 1Recruiting
Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Shanghai Zhongshan HospitalChina
NCT06252649·Phase 3Not yet recr...
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Amgen
NCT06208397Recruiting
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
Shengjing HospitalChina
NCT06149481·Phase 1/2Not yet recr...
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
National Cancer Institute (NCI...United States of America
NCT06225843·Phase 2Recruiting
Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
Alethia BiotherapeuticsCanada
NCT06137170Not yet recr...
A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment
Bayer
NCT06134388·Phase 3Recruiting
Sulfasalazine in Patients With Metastatic Colorectal Cancer
Tanta UniversityEgypt
NCT06118762·Phase 4Recruiting
Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
The First Affiliated Hospital ...China
NCT06109883·Phase 1Not yet recr...
LB-100 (PP2A Inhibitor) and Azenosertib (WEE1 Inhibitor) in Metastatic Colorectal Cancer Patients
The Netherlands Cancer Institu...
NCT06060704·Phase 2Recruiting
Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.
The First Affiliated Hospital ...China
NCT06049901·Phase 3Recruiting
Nitazoxanide in Patients With Metastatic Colorectal Cancer
Tanta UniversityEgypt
About this record

Access comprehensive clinical trial information for Metastatic Colorectal Cancer through Pure Global AI's free database. This collection includes 467 clinical trials across multiple phases including Phase 2, N/A, Phase 3. Currently, 86 trials are actively recruiting participants.

Research for Metastatic Colorectal Cancer is being conducted in China, United States of America, France and 7+ other countries. Leading sponsors include Amgen and Sun Yat-sen University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 467 clinical trials studying Metastatic Colorectal Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Amgen, Sun Yat-sen University, Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD), among others.